Intrauterine RBC Transfusion Dosage
ورودیهای بالینی بیمار
حداقل ۲۰۰ — حداکثر ۵۰۰۰ • واحد: g
حداقل ۵ — حداکثر ۶۰ • واحد: %
حداقل ۲۵ — حداکثر ۶۰ • واحد: %
حداقل ۶۰ — حداکثر ۹۰ • واحد: %
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Small Volume0–20
- Moderate Volume20–60
- Large Volume60–200
The Intrauterine RBC Transfusion Dosage calculates calculating precise transfusion volume to achieve target hematocrit while minimizing risks of over- or under-transfusion. Key inputs include fetal weight g. Scores guide titrating weight-adjusted medication dosing, monitoring developmental safety, and evaluating treatment response. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Estimates volume of donor RBCs needed for intrauterine transfusion (IUT) in fetal anemia cases. Used primarily for severe fetal anemia in hemolytic disease of the fetus and newborn (HDFN) when maternal RBC alloantibodies threaten fetal health. Calculates precise transfusion volume to achieve target hematocrit while minimizing risks of over- or under-transfusion.
Clinical Indication
The Intrauterine RBC Transfusion Dosage is indicated for bedside clinical practice to support Estimates volume of donor RBCs needed for intrauterine transfusion (IUT) in fetal anemia cases. Used primarily for severe fetal anemia in hemolytic disease of the fetus and newborn (HDFN) when maternal RBC alloantibodies threaten fetal health. Calculates precise transfusion volume to achieve target hematocrit while minimizing risks of over- or under-transfusion.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.
Limitations & Contraindications
Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients.
Clinical Pearls & Action Plan
Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice.
Transfusion volume (mL) = Fetoplacental volume × [Hct(goal) - Hct(initial)] / Hct(transfused); Fetoplacental volume = fetal weight (g) × 0.14 mL/g
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| fetal_weight_g | float | Yes | Estimated fetal weight in grams based on biometric measurements from ultrasound(g) |
| initial_hematocrit | float | Yes | Current fetal hematocrit percentage before transfusion(%) |
| goal_hematocrit | float | Yes | Target fetal hematocrit percentage after transfusion (usually 40-45%)(%) |
| transfused_hematocrit | float | Yes | Hematocrit percentage of the donor RBC unit to be transfused (typically 75-85%)(%) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–20 | Small Volume | Small transfusion volume |
| 20–60 | Moderate Volume | Moderate transfusion volume |
| 60–200 | Large Volume | Large transfusion volume |
Evidence-Based References (EBM)
- Mandelbrot L, Daffos F, Forestier F, MacAleese J, Descamps P. Assessment of fetal blood volume for computer-assisted management of in utero transfusion. Fetal Ther. 1988;3(1-2):60-6.
- Liley AW. Intrauterine transfusion of foetus in haemolytic disease. Br Med J. 1963;2(5365):1107-9.
- Society for Maternal-Fetal Medicine (SMFM). Management of alloimmunization during pregnancy. Am J Obstet Gynecol. 2018;218(2):B7-B18.
- Van Kamp IL, Klumper FJ, Oepkes D, Meerman RH, Scherjon SA, Vandenbussche FP, et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol. 2005;192(1):171-7.